Yiqi Xu

448 total citations
10 papers, 352 citations indexed

About

Yiqi Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yiqi Xu has authored 10 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yiqi Xu's work include Cancer-related molecular mechanisms research (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Extracellular vesicles in disease (2 papers). Yiqi Xu is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Extracellular vesicles in disease (2 papers). Yiqi Xu collaborates with scholars based in China, Hong Kong and Australia. Yiqi Xu's co-authors include Yu Ren, Xuan Zhou, Mei Mei, Weiping Tian, Xiaohui Zhao, Xin Song, Chunsheng Kang, Yan Dou, Ting Sun and Zhiyan Zhu and has published in prestigious journals such as Inorganic Chemistry, Molecular Cancer and Analytical and Bioanalytical Chemistry.

In The Last Decade

Yiqi Xu

10 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiqi Xu China 6 233 152 124 90 57 10 352
Jian Yuan Goh Singapore 8 164 0.7× 117 0.8× 118 1.0× 120 1.3× 56 1.0× 14 340
Guiqi Zhu China 8 147 0.6× 137 0.9× 128 1.0× 89 1.0× 83 1.5× 13 376
Zeli Yin China 8 217 0.9× 199 1.3× 100 0.8× 84 0.9× 62 1.1× 11 371
Zhitong Niu China 5 191 0.8× 93 0.6× 138 1.1× 98 1.1× 32 0.6× 6 331
Ryan Lupo United States 6 248 1.1× 111 0.7× 166 1.3× 110 1.2× 35 0.6× 7 399
Yuanxi Huang China 9 180 0.8× 145 1.0× 149 1.2× 39 0.4× 39 0.7× 29 341
Man Xia China 12 253 1.1× 170 1.1× 73 0.6× 86 1.0× 29 0.5× 22 399
Jingbing Lou China 8 188 0.8× 136 0.9× 79 0.6× 75 0.8× 73 1.3× 12 316
Yiyi Ji China 7 166 0.7× 105 0.7× 85 0.7× 51 0.6× 99 1.7× 13 309
Chung‐Chi Hsu Taiwan 8 240 1.0× 115 0.8× 187 1.5× 65 0.7× 79 1.4× 12 379

Countries citing papers authored by Yiqi Xu

Since Specialization
Citations

This map shows the geographic impact of Yiqi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqi Xu more than expected).

Fields of papers citing papers by Yiqi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqi Xu. The network helps show where Yiqi Xu may publish in the future.

Co-authorship network of co-authors of Yiqi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiqi Xu. A scholar is included among the top collaborators of Yiqi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiqi Xu. Yiqi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Huang, Chunhua, Yiqi Xu, Ka‐Wing Cheng, et al.. (2024). Tolerogenic dendritic cell-mediated regulatory T cell differentiation by Chinese herbal formulation attenuates colitis progression. Journal of Advanced Research. 70. 499–513. 5 indexed citations
2.
Xu, Hengyue, Yiqi Xu, Zhi‐Wu Yu, et al.. (2024). Deciphering the Nitrogen Activation Mechanisms on Group VIII Single Atoms at MoS2. Inorganic Chemistry. 63(42). 19570–19581. 5 indexed citations
3.
Xu, Jiayao, et al.. (2023). Enhancing intracellular mRNA precise imaging-guided photothermal therapy with a nucleic acid-based polydopamine nanoprobe. Analytical and Bioanalytical Chemistry. 416(4). 849–859. 3 indexed citations
4.
Qiao, Yu, Chao Liu, Xiaoyue Zhang, et al.. (2021). PD-L2 based immune signature confers poor prognosis in HNSCC. OncoImmunology. 10(1). 1947569–1947569. 31 indexed citations
5.
Bao, Qiyuan, Zhuochao Liu, Junxiang Wen, et al.. (2021). Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration. Frontiers in Cell and Developmental Biology. 9. 633607–633607. 47 indexed citations
6.
Liu, Qi, Qiyuan Bao, Yiqi Xu, et al.. (2021). MCM4 Is a Novel Biomarker Associated With Genomic Instability, BRCAness Phenotype, and Therapeutic Potentials in Soft-Tissue Sarcoma. Frontiers in Cell and Developmental Biology. 9. 666376–666376. 4 indexed citations
7.
Xu, Yiqi, Qiyuan Bao, Qi Liu, et al.. (2021). A Novel Microfluidic Chip for Fast, Sensitive Quantification of Plasma Extracellular Vesicles as Biomarkers in Patients With Osteosarcoma. Frontiers in Oncology. 11. 709255–709255. 16 indexed citations
8.
Liu, Qi, Qiyuan Bao, Junxiang Wen, et al.. (2021). Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasis. Hereditas. 158(1). 9–9. 4 indexed citations
9.
Xu, Yiqi, Yuqing Wang, Yuhong Wang, et al.. (2021). PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy. Journal for ImmunoTherapy of Cancer. 9(10). e002699–e002699. 63 indexed citations
10.
Ren, Yu, Huanhuan Jia, Yiqi Xu, et al.. (2018). Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion. Molecular Cancer. 17(1). 5–5. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026